SARS‐CoV‐2 main protease inhibitory efficacy of natural peptidic α‐hydroxy amides for therapeutic applications of COVID‐19.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.03597
- By:
- Publication type:
- Article
Works matching AU Venkateshwar, Madka
Results: 17
1
2
Targeting Thyroid Hormone Receptor Interacting Protein (TRIP13) for Cancer Therapy: A Promising Approach.
- Published in:
- DNA (2673-8856), 2025, v. 5, n. 1, p. 3, doi. 10.3390/dna5010003
- By:
- Publication type:
- Article
3
Correction: Singh et al. Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models. Cells 2024, 13 , 1463.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
4
Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 17, p. 1463, doi. 10.3390/cells13171463
- By:
- Publication type:
- Article
5
Molecular Mechanisms of Cancer Prevention by Gooseberry (Phyllanthus emblica).
- Published in:
- Nutrition & Cancer, 2022, v. 74, n. 7, p. 2291, doi. 10.1080/01635581.2021.2008988
- By:
- Publication type:
- Article
6
Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 24, p. 9609, doi. 10.3390/ijms21249609
- By:
- Publication type:
- Article
7
Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 8, p. 2332, doi. 10.3390/ijms19082332
- By:
- Publication type:
- Article
8
Prevention and treatment of cancers by immune modulating nutrients.
- Published in:
- Molecular Nutrition & Food Research, 2016, v. 60, n. 6, p. 1275, doi. 10.1002/mnfr.201500884
- By:
- Publication type:
- Article
9
Development of a dietary formulation of the SHetA2 chemoprevention drug for mice.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 561, doi. 10.1007/s10637-017-0550-0
- By:
- Publication type:
- Article
10
Targeting cholecystokinin‐2 receptor for pancreatic cancer chemoprevention.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 10, p. 1908, doi. 10.1002/mc.23084
- By:
- Publication type:
- Article
11
Correction: Panneerselvam et al. Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism. Cancers 2021, 13 , 5159.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
12
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 4001, doi. 10.3390/cancers15154001
- By:
- Publication type:
- Article
13
Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5159, doi. 10.3390/cancers13205159
- By:
- Publication type:
- Article
14
Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
- Published in:
- Oncology Reports, 2015, v. 34, n. 6, p. 2925, doi. 10.3892/or.2015.4277
- By:
- Publication type:
- Article
15
Molecular disparities in colorectal cancers of White Americans, Alabama African Americans, and Oklahoma American Indians.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00433-5
- By:
- Publication type:
- Article
16
Chromatin Remodulator CHD4: A Potential Target for Cancer Interception.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
17
Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases.
- Published in:
- Journal of Inflammation Research, 2020, v. 13, p. 1261, doi. 10.2147/JIR.S286110
- By:
- Publication type:
- Article